Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Clinical Psychopharmacology|April 6, 2018
Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar DisorderShefali Miller, Dennis Do, Anda Gershon, et al.International Journal of Bipolar Disorders|July 31, 2016
Current irritability associated with hastened depressive recurrence and delayed depressive recovery in bipolar disorderLaura D Yuen, Saloni Shah, Dennis Do, et al.Journal of Clinical Psychopharmacology|November 8, 2012
Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorderShefali Miller, Pichai Ittasakul, Po W Wang, et al.Journal of Affective Disorders|August 28, 2017
Subjective versus objective evening chronotypes in bipolar disorderAnda Gershon, Christopher N Kaufmann, Colin A Depp, et al.Journal of Psychiatric Research|February 28, 2016
Different characteristics associated with suicide attempts among bipolar I versus bipolar II disorder patientsKathryn C Goffin, Bernardo Dell'Osso, Shefali Miller, et al.International Journal of Bipolar Disorders|January 27, 2017
American tertiary clinic-referred bipolar II disorder versus bipolar I disorder associated with hastened depressive recurrenceBernardo Dell'Osso, Saloni Shah, Dennis Do, et al.Journal of Affective Disorders|December 25, 2012
Superior chronic tolerability of adjunctive modafinil compared to pramipexole in treatment-resistant bipolar disorderBernardo Dell'osso, Sara Timtim, Farnaz Hooshmand, et al.Depression and Anxiety|April 29, 2015
COGNITION-CHILDHOOD MALTREATMENT INTERACTIONS IN THE PREDICTION OF ANTIDEPRESSANT OUTCOMES IN MAJOR DEPRESSIVE DISORDER PATIENTS: RESULTS FROM THE iSPOT-D TRIALShefali Miller, Lisa M McTeague, Anett Gyurak, et al.Journal of Psychiatric Research|May 25, 2016
Current irritability robustly related to current and prior anxiety in bipolar disorderLaura D Yuen, Shefali Miller, Po W Wang, et al.CNS Spectrums|May 23, 2024
A double-blind, randomized, placebo-controlled plus open trial of adjunctive suvorexant for treatment-resistant insomnia in patients with bipolar disorderRita Cafaro, Monica Macellaro, Trisha Suppes, et al.Pageof 4